Literature DB >> 11781067

Animal models of human disease: experimental autoimmune gastritis--a model for autoimmune gastritis and pernicious anemia.

Frank Alderuccio1, John W Sentry, Aiden C J Marshall, Mark Biondo, Ban Hock Toh.   

Abstract

Human autoimmune gastritis is an organ-specific autoimmune disease of the stomach. It is characterized by the development of disease-specific autoantibodies and a pathology that specifically targets specialized cells within the gastric environment. The autoantigens associated with this disease have been defined as the gastric H+/K+ ATPase and intrinsic factor. The development of experimental disease models has been pivotal in our contemporary understanding of autoimmunity. Here we review mouse models of autoimmune gastritis and their relevance to human autoimmune gastritis associated with pernicious anemia. We appraise some historical as well as recent studies of experimental autoimmune gastritis (EAG), highlighting key findings that have formed the basis of our current understanding of the etiology and mechanism(s) associated with autoimmune gastritis. A precise understanding of the pathogenesis of autoimmune gastritis will permit the design of innovative and rational therapeutic strategies to prevent, arrest, ameliorate or reverse the disease. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781067     DOI: 10.1006/clim.2001.5134

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Lack of specific association between gastric autoimmunity hallmarks and clinical presentations of atrophic body gastritis.

Authors:  Bruno Annibale; Edith Lahner; Riccardo Negrini; Flavia Baccini; Cesare Bordi; Bruno Monarca; Gianfranco Delle Fave
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

Review 2.  Cutting edge issues in autoimmune gastritis.

Authors:  Ban-Hock Toh; James Chan; Tin Kyaw; Frank Alderuccio
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 3.  Pathophysiology and laboratory diagnosis of pernicious anemia.

Authors:  Ban-Hock Toh
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 4.  Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia.

Authors:  Gerhard Faller; Thomas Kirchner
Journal:  Virchows Arch       Date:  2004-12-04       Impact factor: 4.064

Review 5.  Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma.

Authors:  Mathijs P Bergman; Mario M D'Elios
Journal:  J Biomed Biotechnol       Date:  2010-06-22

6.  A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic:polycytidylic acid.

Authors:  Y Kobayashi; H Murakami; S M F Akbar; H Matsui; M Onji
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

7.  Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases.

Authors:  Nadine Dragin; Jacky Bismuth; Géraldine Cizeron-Clairac; Maria Grazia Biferi; Claire Berthault; Alain Serraf; Rémi Nottin; David Klatzmann; Ana Cumano; Martine Barkats; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  J Clin Invest       Date:  2016-03-21       Impact factor: 14.808

8.  Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells.

Authors:  Georg H Stummvoll; Richard J DiPaolo; Eva N Huter; Todd S Davidson; Deborah Glass; Jerrold M Ward; Ethan M Shevach
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

9.  Optimal management of pernicious anemia.

Authors:  Emmanuel Andres; Khalid Serraj
Journal:  J Blood Med       Date:  2012-09-10

10.  Increased risk of pernicious anemia following scabies: a nationwide population-based matched-cohort study.

Authors:  Jui-Ming Liu; Ren-Jun Hsu; Fung-Wei Chang; Feng-Hsiang Chiu; Chia-Lun Yeh; Chun-Fa Huang; Shu-Ting Chang; Hung-Chang Lee; Hsin Chi; Chien-Yu Lin
Journal:  Ther Clin Risk Manag       Date:  2017-09-13       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.